IBM Watson Turns Oncogenes Into Drug Targets

News   Aug 09, 2017 | Original story from Medical College of Georgia at Augusta University

 
IBM Watson Turns Oncogenes Into Drug Targets

Dr. Ravindra Kolhe, breast and molecular pathologist at the Medical College of Georgia at Augusta University

 
 
 

RELATED ARTICLES

Anti-stress Compound Reduces Obesity and Diabetes

News

Scientists could prove that a stress protein found in muscle has a diabetes promoting effect. This finding could pave the way to a completely new treatment approach.

READ MORE

First Successful Gene Therapy Trial Reported for People with Hemophilia A

News

Patients with hemophilia A who received a single infusion of an investigational gene therapy showed improved levels of the essential blood clotting protein FVIII, with 11 of 13 achieving normal or near-normal FVIII levels.

READ MORE

Some Immune Cells May Help Tumors Instead of Destroying Them

News

New data shows that neutrophils promote tumor progression and can actually hamper the work of immunotherapy in lung cancer.

READ MORE

 

Comments | 0 ADD COMMENT

Like what you just read? You can find similar content on the communities below.

Cancer Research Drug Discovery Informatics & Automation

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE